DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Cars.com
CARS
Collegium Pharmaceutical
COLL
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | -40.92%987.83M | -23.83%800.78M | -48.44%788.66M | 236.91%1.35B | 236.91%1.35B | 293.24%1.67B | 153.08%1.05B | 250.16%1.53B | -8.15%402M | -8.15%402M |
-Cash and cash equivalents | -40.92%987.83M | -23.83%800.78M | -48.44%788.66M | 236.91%1.35B | 236.91%1.35B | 293.24%1.67B | 153.08%1.05B | 250.16%1.53B | -8.15%402M | -8.15%402M |
Receivables | 9.23%114.12M | 15.76%102.28M | 17.01%106.06M | 13.15%94.53M | 13.15%94.53M | 11.98%104.48M | 9.97%88.35M | 11.26%90.64M | 8.95%83.54M | 8.95%83.54M |
-Accounts receivable | 9.23%114.12M | 15.76%102.28M | 17.01%106.06M | 13.15%94.53M | 13.15%94.53M | 11.98%104.48M | 9.97%88.35M | 11.26%90.64M | 8.95%83.54M | 8.95%83.54M |
Net loan | 6.58%17.02B | 5.63%16.69B | 7.91%16.56B | 6.26%16.02B | 6.26%16.02B | 8.69%15.97B | 10.80%15.8B | 12.79%15.35B | 13.19%15.08B | 13.19%15.08B |
-Gross loan | 6.58%17.23B | 5.64%16.89B | 7.90%16.76B | 6.26%16.21B | 6.26%16.21B | 8.68%16.16B | 10.78%15.99B | 12.70%15.53B | 13.09%15.26B | 13.09%15.26B |
-Allowance for loans and lease losses | 6.71%205.17M | 6.11%200.96M | 6.52%198.78M | 5.75%192.76M | 5.75%192.76M | 7.90%192.27M | 9.49%189.39M | 5.93%186.6M | 5.57%182.28M | 5.57%182.28M |
Securities and investments | -5.10%7.88B | -6.92%8.02B | -7.81%8.19B | -8.83%8.3B | -8.83%8.3B | -13.02%8.31B | -14.08%8.62B | -12.24%8.89B | -12.29%9.1B | -12.29%9.1B |
-Available for sale securities | 767.48%98.29M | 1,116.40%121.81M | 374.63%111.13M | -84.45%12.76M | -84.45%12.76M | -70.35%11.33M | -69.85%10.01M | 77.15%23.41M | 718.51%82.02M | 718.51%82.02M |
-Held to maturity securities | -5.77%3.35B | -5.76%3.4B | -5.81%3.45B | -5.72%3.5B | -5.72%3.5B | -5.40%3.55B | -4.76%3.61B | 2.44%3.66B | 209.80%3.72B | 209.80%3.72B |
-Short term investments | -6.44%4.44B | -10.01%4.5B | -10.95%4.63B | -9.83%4.79B | -9.83%4.79B | -17.61%4.74B | -19.48%5B | -20.46%5.2B | -42.13%5.31B | -42.13%5.31B |
Bank owned life insurance | 11.05%188.97M | 10.99%187.79M | 10.93%186.63M | 1.20%171.1M | 1.20%171.1M | 1.18%170.18M | 0.57%169.2M | 0.56%168.24M | 0.83%169.07M | 0.83%169.07M |
Net PPE | 12.43%466.98M | 11.37%451.52M | 10.89%443.27M | 5.95%421.79M | 5.95%421.79M | 4.98%415.34M | 4.97%405.41M | 7.13%399.74M | 6.84%398.1M | 6.84%398.1M |
-Gross PPE | ---- | ---- | ---- | 6.86%622.95M | 6.86%622.95M | ---- | ---- | ---- | 6.72%582.95M | 6.72%582.95M |
-Accumulated depreciation | ---- | ---- | ---- | -8.82%-201.16M | -8.82%-201.16M | ---- | ---- | ---- | -6.45%-184.85M | -6.45%-184.85M |
Foreclosed assets | 1,218.75%633K | 1,111.54%630K | 2,774.19%891K | 4,596.88%1.5M | 4,596.88%1.5M | 14.29%48K | -86.28%52K | -27.91%31K | 77.78%32K | 77.78%32K |
Goodwill and other intangible assets | 8.50%1.11B | 4.37%1.07B | 4.42%1.07B | -0.95%1.02B | -0.95%1.02B | -0.97%1.02B | -0.99%1.02B | -1.01%1.02B | -1.03%1.03B | -1.03%1.03B |
-Goodwill | 6.92%1.05B | 3.89%1.02B | 3.89%1.02B | 0.00%985.39M | 0.00%985.39M | 0.00%985.39M | 0.00%985.39M | 0.00%985.39M | 0.00%985.39M | 0.00%985.39M |
-Other intangible assets | 53.89%52.78M | 17.16%43.03M | 17.61%46.05M | -23.39%31.87M | -23.39%31.87M | -22.52%34.3M | -21.75%36.73M | -21.05%39.15M | -20.39%41.6M | -20.39%41.6M |
Other assets | 55.41%309.76M | 69.78%327.19M | 69.49%312.98M | 10.97%201.13M | 10.97%201.13M | 15.96%199.32M | 14.48%192.72M | 19.52%184.67M | 50.46%181.24M | 50.46%181.24M |
Total assets | 0.51%28.21B | 1.01%27.81B | 0.07%27.82B | 4.16%27.74B | 4.16%27.74B | 4.98%28.06B | 3.14%27.53B | 6.52%27.8B | 2.68%26.64B | 2.68%26.64B |
Liabilities | ||||||||||
Total deposits | 1.57%20.71B | 0.47%20.1B | 1.39%20.43B | -3.29%19.93B | -3.29%19.93B | -6.78%20.4B | -8.15%20.01B | -7.14%20.15B | -3.42%20.61B | -3.42%20.61B |
Federal funds purchased and securities sold under agreement to repurchase | 22.12%1.83B | 20.09%1.63B | 29.27%1.54B | 57.19%1.49B | 57.19%1.49B | 68.98%1.5B | 40.14%1.36B | 24.29%1.19B | -7.34%945.92M | -7.34%945.92M |
Payables | -61.49%35.38M | -35.07%31M | 263.34%32.58M | 2,807.11%125.91M | 2,807.11%125.91M | 3,253.07%91.87M | 1,945.50%47.74M | 292.64%8.97M | 79.78%4.33M | 79.78%4.33M |
-Accounts payable | -61.49%35.38M | -35.07%31M | 263.34%32.58M | 2,807.11%125.91M | 2,807.11%125.91M | 3,253.07%91.87M | 1,945.50%47.74M | 292.64%8.97M | 79.78%4.33M | 79.78%4.33M |
Long term debt and capital lease obligation | -31.54%2.02B | -12.80%2.57B | -28.08%2.36B | 46.99%2.95B | 46.99%2.95B | 221.89%2.95B | 278.57%2.95B | 1,116.66%3.28B | 1,037.47%2.01B | 1,037.47%2.01B |
-Long term debt | -31.54%2.02B | -12.80%2.57B | -28.08%2.36B | 46.99%2.95B | 46.99%2.95B | 221.89%2.95B | 278.57%2.95B | 1,116.66%3.28B | 1,037.47%2.01B | 1,037.47%2.01B |
Other liabilities | 41.58%361.84M | 39.57%334.46M | 43.83%349.39M | 0.26%225.79M | 0.26%225.79M | -7.17%255.58M | -8.06%239.64M | 2.26%242.92M | -0.29%225.19M | -0.29%225.19M |
Total liabilities | -0.91%24.96B | 0.27%24.67B | -0.66%24.71B | 3.91%24.72B | 3.91%24.72B | 5.13%25.19B | 3.39%24.6B | 7.38%24.88B | 4.52%23.79B | 4.52%23.79B |
Shareholders'equity | ||||||||||
Share capital | 2.25%1.13M | 2.25%1.13M | 2.25%1.13M | 0.09%1.11M | 0.09%1.11M | 0.09%1.11M | 0.09%1.11M | 0.09%1.11M | 0.09%1.11M | 0.09%1.11M |
-common stock | 2.25%1.13M | 2.25%1.13M | 2.25%1.13M | 0.09%1.11M | 0.09%1.11M | 0.09%1.11M | 0.09%1.11M | 0.09%1.11M | 0.09%1.11M | 0.09%1.11M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Paid-in capital | 4.21%2.45B | 4.22%2.45B | 4.23%2.44B | 0.26%2.35B | 0.26%2.35B | 0.25%2.35B | 0.23%2.35B | 0.22%2.34B | 0.22%2.34B | 0.22%2.34B |
Retained earnings | 3.26%1.06B | 3.54%1.05B | 4.72%1.04B | 7.88%1.04B | 7.88%1.04B | 11.00%1.03B | 14.59%1.01B | 17.83%991.51M | 19.33%966.98M | 19.33%966.98M |
Gains losses not affecting retained earnings | 47.58%-262.31M | 17.67%-354.65M | 9.24%-372.31M | 20.20%-374.11M | 20.20%-374.11M | -1.05%-500.37M | -31.65%-430.79M | -65.54%-410.23M | -1,813.48%-468.79M | -1,813.48%-468.79M |
Total stockholders'equity | 12.89%3.25B | 7.21%3.14B | 6.28%3.11B | 6.22%3.02B | 6.22%3.02B | 3.69%2.87B | 1.05%2.93B | -0.25%2.93B | -10.52%2.84B | -10.52%2.84B |
Total equity | 12.89%3.25B | 7.21%3.14B | 6.28%3.11B | 6.22%3.02B | 6.22%3.02B | 3.69%2.87B | 1.05%2.93B | -0.25%2.93B | -10.52%2.84B | -10.52%2.84B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |